Compare Liquidia Corporation Common Stock (LQDA) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Wells Fargo & Co — how do they compare? Liquidia Corporation Common Stock trades at $33.75 (market cap $3.04B), while Wells Fargo & Co trades at $81.49 (market cap $242.83B). The key difference: Wells Fargo & Co is far larger — about 79.9× Liquidia Corporation Common Stock's market cap, and Wells Fargo & Co pays a 2.47% dividend while Liquidia Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Wells Fargo & Co for 88 Days on average.
| LQDA | WFC | |
|---|---|---|
Market Cap | $3.04B | $242.83B |
Volume | 21,111,778 | 21,447,763 |
Sector | Health | Financials |
52-Week High | $91.03 | $96.40 |
52-Week Low | $22.02 | $73.42 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $2.94B | $425.14B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wells Fargo (WFC) trades at $80.74, down 3.07% on the day, amid mixed technical signals with a bullish overall signal but bearish moving averages. The company shows solid fundamentals with a P/E of 11.76, net income margin of 25.97%, and recent earnings beats in Q2 and Q3 2026. Positive developments include a credit rating upgrade to 'A-' by S&P (Zacks Investment Research, 2026-10-01) and a renewed mortgage servicing agreement with Intercontinental Exchange (Business Wire, 2026-09-29).
The outlook is supported by analyst consensus with a $98 price target and a balanced buy/hold rating split, though risks include volatile cash flows and regulatory changes from Fed stress test overhauls (Reuters, 2026-09-30). Upside potential hinges on continued earnings growth and NII expansion from rate hikes, while downside risks involve execution challenges and macroeconomic pressures on banking stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
